EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudieOpen Access · CC BY-NC 4.0

Comparative Efficacy of Mycophenolate Mofetil vs. Azathioprine in Autoimmune Hepatitis: A Systematic Review and Meta-Analysis

Momen Mohamed Ibrahim, Bisher Sawaf, Noheir Ashraf Ibrahem Fathy Hassan, Momen Hassan Moussa, Mayar Ibrahim, Karam R Motawea, Muhammed Elhadi, Yaseen Alastal

Digestion · 2025

DOI: 10.1159/000548140 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Digestion, 2025. Verfasst von Momen Mohamed Ibrahim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Alexandria University, Alexandria, Egypt. Hauptthemen laut MEDLINE: Azathioprine, Hepatitis, Autoimmune, Immunosuppressive Agents, Mycophenolic Acid. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Azathioprine (AZA) is the standard treatment for both induction and maintenance of response in autoimmune hepatitis (AIH). However, lifelong administration is often required, and the combination therapy of prednisolone and AZA raises significant concerns regarding efficacy and tolerability, especially given the high relapse rates following AZA cessation. Consequently, there is a need to explore alternative treatment options. This systematic review and meta-analysis compared the efficacy and safety of mycophenolate mofetil (MMF) versus AZA, combined with prednisolone, for treating AIH.

Methods

PubMed, Cochrane, Scopus, and Web of Science were searched to identify randomized clinical trials and cohort studies comparing AZA and MMF for treating AIH. Four studies compared steroid withdrawal and complete biochemical response (CBR) between the MMF and AZA groups. Subgroup analyses were performed based on age (above and below 50 years) and IgG levels (above and below 2,400 mg/dL). RevMan (version 5.4) software was used for meta-analysis.

Results

Four studies (three cohort studies and one RCT) comprising 505 patients were included in the final analysis. The pooled analysis showed a statistically significant association between the MMF group, while it increased CBR compared with the AZA group (RR = 1.44, 95% CI = 1.03–2.01, p value = 0.03), with no significant difference between the two groups regarding steroid withdrawal. Subgroup analysis by age revealed a significant association between the MMF group and increased CBR in patients over 50 years (RR = 1.63, 95% CI = 1.00–2.64, p value = 0.05). IgG subgroup analysis indicated a significant association between the MMF group and increased biochemical remission compared with the AZA group in patients with IgG levels less than 2,400 mg/dL (RR = 1.63, 95% CI = 1.00–2.64, p value = 0.05).

Conclusion

The use of MMF was significantly associated with increased CBR compared to AZA in patients with AIH. Additionally, there was no significant association between the two groups regarding steroid withdrawal. Further research is needed to fully elucidate the optimal treatment strategy for AIH patients across different subpopulations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzathioprineHepatitis, AutoimmuneImmunosuppressive AgentsMycophenolic AcidHumansDrug Therapy, CombinationPrednisoloneRandomized Controlled Trials as TopicRecurrenceRemission InductionTreatment Outcome

Stichwörter der Autor:innen

Autoimmune hepatitisAzathioprineBiochemical remissionMeta-analysisMycophenolate mofetil

Substanzen

AzathioprineImmunosuppressive AgentsMycophenolic AcidPrednisolone

Autor:innen und Institutionen

  • Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • University of Toledo Internal Medicine Program (UTMC), Toledo, Ohio, USA.
  • Faculty of Medicine, Aswan University, Aswan, Egypt.
  • Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt.
  • College of Medicine, Korea University, Seoul, Republic of Korea, muhammed-elhadi@korea.ac.kr.
  • Department of Gastroenterology, University of Toledo, Toledo, Ohio, USA.

Zitieren

APA

Ibrahim, M. M., Sawaf, B., Hassan, N. A. I. F., Moussa, M. H., Ibrahim, M., Motawea, K. R., Elhadi, M., & Alastal, Y. (2025). Comparative Efficacy of Mycophenolate Mofetil vs. Azathioprine in Autoimmune Hepatitis: A Systematic Review and Meta-Analysis. Digestion. https://doi.org/10.1159/000548140

Vancouver

Ibrahim MM, Sawaf B, Hassan NAIF, Moussa MH, Ibrahim M, Motawea KR, et al. Comparative Efficacy of Mycophenolate Mofetil vs. Azathioprine in Autoimmune Hepatitis: A Systematic Review and Meta-Analysis. Digestion. 2025. doi:10.1159/000548140

BibTeX
@article{Ibrahim2025,
  author = {Ibrahim, Momen Mohamed and Sawaf, Bisher and Hassan, Noheir Ashraf Ibrahem Fathy and Moussa, Momen Hassan and Ibrahim, Mayar and Motawea, Karam R and Elhadi, Muhammed and Alastal, Yaseen},
  title = {Comparative Efficacy of Mycophenolate Mofetil vs. Azathioprine in Autoimmune Hepatitis: A Systematic Review and Meta-Analysis},
  journal = {Digestion},
  year = {2025},
  doi = {10.1159/000548140}
}
Kostenlos starten →